Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$1.8 million.

  • CureVac N.V's Cash from Investing Activities rose 78.17% to -$1.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$8.7 million, marking a year-over-year increase of 80.17%. This contributed to the annual value of -$19.7 million for FY2024, which is 66.82% up from last year.
  • According to the latest figures from Q2 2025, CureVac N.V's Cash from Investing Activities is -$1.8 million, which was down 227.47% from -$537,513 recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Cash from Investing Activities peaked at $106.6 billion during Q4 2021, and registered a low of -$88.7 billion during Q2 2021.
  • Over the past 3 years, CureVac N.V's median Cash from Investing Activities value was -$6.8 million (recorded in 2024), while the average stood at -$8.2 million.
  • Per our database at Business Quant, CureVac N.V's Cash from Investing Activities soared by 321,593.84% in 2021 and then tumbled by 43,861.61% in 2022.
  • Over the past 5 years, CureVac N.V's Cash from Investing Activities (Quarterly) stood at $106.6 billion in 2021, then tumbled by 100.02% to -$21.4 million in 2022, then increased by 27.43% to -$15.5 million in 2023, then soared by 82.29% to -$2.7 million in 2024, then skyrocketed by 78.17% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q2 2025, -$537,513 for Q1 2025, and -$2.7 million during Q4 2024.